Gelesis Holdings - Stock Split History | GLS

Stock split history for Gelesis Holdings since 2022. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Gelesis Holdings Annual Stock Splits
Gelesis Holdings Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.078B $0.011B
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $153.119B 9.29
GSK (GSK) United Kingdom $59.709B 7.17
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.856B 0.00
QIAGEN (QGEN) Netherlands $9.360B 15.67
Ginkgo Bioworks Holdings (DNA) United States $5.587B 0.00
Arcus Biosciences (RCUS) United States $1.842B 35.96
Myovant Sciences (MYOV) United Kingdom $1.684B 0.00
Emergent Biosolutions (EBS) United States $1.036B 6.01
ADC Therapeutics SA (ADCT) Switzerland $0.376B 0.00
Zymeworks (ZYME) Canada $0.336B 0.00
Enzo Biochem (ENZ) United States $0.107B 0.00
SQZ Biotechnologies (SQZ) United States $0.065B 0.00
Ambrx Biopharma (AMAM) United States $0.042B 0.00